Volume 3 Supplement 1

Innovative Rheumatology: Gene and Cell Therapies of Arthritis and Related Autoimmune Disorders. Second International Meeting

Open Access

Transfer of protease inhibitors to inhibit cartilage destruction

  • WH van der Laan1, 2,
  • T Pap3,
  • PHA Quax2,
  • JM TeKoppele2,
  • FC Breedveld1,
  • S Gay3,
  • RE Gay3,
  • JH Verheijen2 and
  • TWJ Huizinga1
Arthritis Research & Therapy20013(Suppl 1):P16

DOI: 10.1186/ar341

Received: 6 April 2001

Published: 25 April 2001

Objective

Proteases such as serine proteases and matrix metalloproteases (MMPs) are involved in cartilage destruction in rheumatoid arthritis. The effects of gene transfer of plasmin inhibitors and tissue inhibitors of metalloproteinases (TIMPs) on cartilage degradation and invasion by rheumatoid synovial fibroblasts were investigated.

Method

Replication defective adenoviral vectors were used for transduction. Genes encoding the following inhibitors were used: the plasmin inhibitor, bovine pancreatic trypsin inhibitor (BPTI); a cell surface-targeted plasmin inhibitor, ATF.BPTI, a hybrid protein of BPTI and a ligand of the cell surface uPA-receptor, ATF; TIMP-1; and TIMP-3. Cartilage degradation was investigated in an in vitro model using a radiolabeled cartilage-like matrix. The invasive behavior of rheumatoid synovial fibroblasts was studied in vitro in a Transwell model and in vivo in the SCID mouse co-implantation model.

Results and conclusion

Cartilage degradation was significantly reduced by gene transfer of BPTI and ATF.BPTI. The effect of ATF.BPTI was significantly stronger than that of BPTI suggesting that targeting protease inhibition to the cell surface improves the inhibitory effect. Gene transfer of ATF.BPTI, TIMP-1 and TIMP-3 significantly inhibited cartilage invasion. These results indicate that cartilage degradation and invasion can be inhibited by gene transfer of inhibitors of plasmin and MMPs. Inhibition of proteases at the site of joint destruction through gene transfer may provide a novel therapeutic strategy to limit the progression of joint destruction in rheumatoid arthritis.

Authors’ Affiliations

(1)
Department of Rheumatology, Leiden University Medical Center
(2)
Department of Vascular and Connective Tissue Research, TNO Prevention and Health
(3)
Center for Experimental Rheumatology, UniversitätsSpital Zürich

Copyright

© BioMed Central Ltd 2001

Advertisement